Yahoo Web Search

  1. Ads
    related to "multiple sclerosis"
  1. Yahoo Finance Results

  2. Paris, January 4 2018, 5.45pm AB Science announces that based on interim analysis, IDMC recommended the continuation of the masitinib phase 3 study in progressive forms of multiple sclerosis ...

  3. SOUTH SAN FRANCISCO, Calif., Jan. 10, 2018-- Atara Biotherapeutics, Inc., a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral ...

  4. According to the most recent quarterly update from Spherix Global Insights, multiple sclerosis-focused neurologists report increased use of monoclonal antibody disease-modifying therapies and a recent ...

  5. 2017 turned out to be a pretty good year for pharma and biotech stocks where FDA decisions are concerned. The regulatory body approved 46 novel drugs last year, easily surpassing 2016’s total ...

  6. 3 Top Value Stocks to Buy in 2018

    Motley Fool via Yahoo FinanceDec 31 20:00 PM

    Value stocks, or stocks with solid fundamentals but lower valuations than their peers, have historically outperformed growth stocks by a wide margin. As such, I think investors may want to consider ...

  7. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Synergy Pharmaceuticals ...

  8. GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) investors will be smiling to hear the drug maker's good news today: FDA acceptance for filing with Priority Review of GWPH's NDA for the company's investigational ...

  9. 3 Big Biotech Stocks to Buy in January

    Motley Fool via Yahoo FinanceJan 06 15:34 PM

    Many biotech stocks performed even better than that. Amgen (NASDAQ: AMGN) stock, for example, jumped 19% -- good, but not great for a year like 2017. I think Amgen, Celgene, and Vertex look ...

  10. Through the partnership, qualified patients will immediately be able to access IQuity's unique, patented diagnostic test, IsolateMS™, to assist their providers in determining whether they might ...

  11. Brainstorm Issues 2017 Letter to Shareholders

    PR Newswire via Yahoo FinanceDec 29 8:54 AM

    BrainStorm Cell Therapeutics Inc. BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today issued a Letter to Shareholders from its President and CEO, ...

  1. Ads
    related to "multiple sclerosis"
  2. See more ads for: